Prudential Financial’s Assembly Biosciences ASMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,648
Closed -$32K 2595
2022
Q3
$32K Buy
1,648
+233
+16% +$5.64K ﹤0.01% 2595
2022
Q2
$36K Buy
+1,415
New +$32.6K ﹤0.01% 2589
2020
Q4
Sell
-10,744
Closed -$2.12M 2446
2020
Q3
$2.12M Sell
10,744
-263
-2% -$66.2K ﹤0.01% 1299
2020
Q2
$3.08M Buy
11,007
+76
+0.7% +$17.7K 0.01% 1154
2020
Q1
$1.95M Buy
10,931
+883
+9% +$189K ﹤0.01% 1374
2019
Q4
$2.47M Sell
10,048
-9,044
-47% -$1.67M ﹤0.01% 1511
2019
Q3
$2.44M Buy
19,092
+6,853
+56% +$1.04M ﹤0.01% 1495
2019
Q2
$1.98M Sell
12,239
-733
-6% -$139K ﹤0.01% 1609
2019
Q1
$3.06M Buy
+12,972
New +$3.28M 0.01% 1372

Other funds holding ASMB

Prudential Financial's ASMB Position: Q4 2022 in Review

Prudential Financial sold out of Assembly Biosciences (ASMB) in Q4 2022, closing a stake of 1,648 shares — an estimated $32K sold.

Prudential Financial first reported a position in ASMB in Q1 2019 and held it in 9 quarters. The position peaked at $3.08M in Q2 2020. 39 funds tracked by Wall St. Rank hold ASMB as of Q4 2022.

  • Prudential Financial reported no remaining Assembly Biosciences position as of Q4 2022 after selling out during the quarter.
  • Prudential Financial sold 1,648 Assembly Biosciences shares in Q4 2022, an estimated $32K.
  • Prudential Financial first reported a position in Assembly Biosciences in Q1 2019 and held it in 9 quarters.
  • Prudential Financial's Assembly Biosciences position peaked at $3.08M in Q2 2020.
  • 39 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2022.

Based on Prudential Financial's 13F filing for Q4 2022, filed 14 Feb 2023.